ad
This Article
Right arrow Images Only
Right arrow Full Version
Right arrow PDF Español
Services
Right arrow E-mail this link to a friend
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Section 1
Section 2
Section 3
Section 4
Section 5
Appendices
Right arrow Earn CME - What's This?
Related Collections
Right arrowRelated Articles

The following text is from an archived Red Book® edition and may not reflect current recommendations or information. To view the current edition, click here.

Section 3. Summaries of Infectious Diseases

Influenza

Clinical Manifestations
Etiology
Epidemiology
Diagnostic Tests
Treatment
Isolation of the Hospitalized Patient
Control Measures

CLINICAL MANIFESTATIONS:
Influenza classically is characterized by sudden onset of fever, often with chills or rigors, headache, malaise, diffuse myalgia, and a nonproductive cough. Subsequently, the respiratory tract signs of sore throat, nasal congestion, rhinitis, and cough become more prominent. Conjunctival injection, abdominal pain, nausea, and vomiting can occur. In some children, influenza can appear as an upper respiratory tract infection or as a febrile illness with few respiratory tract signs. In young infants, influenza can produce a sepsis-like picture and occasionally can cause croup, bronchiolitis, or pneumonia. Acute myositis characterized by calf tenderness and refusal to walk may develop after several days of influenza illness, particularly with type B infection. Reye syndrome has been associated with influenza infection, primarily with influenza B. Influenza can alter the metabolism of certain medications, especially theophylline, potentially resulting in the development of toxic effects from high serum concentrations.


ETIOLOGY:
Influenza viruses are orthomyxoviruses of 3 antigenic types (A, B, and C). Epidemic disease is caused by influenza virus types A and B. Influenza A viruses are subclassified by 2 surface antigens, hemagglutinin (HA) and neuraminidase (NA). Viruses bearing 3 immunologically distinct hemagglutinin subtypes (H1, H2, and H3) and 2 neuraminidase subtypes (N1 and N2) have been recognized as causing global human epidemics. Specific antibodies to these various antigens, especially hemagglutinin, are important determinants of immunity. Major changes leading to the emergence of a new hemagglutinin, such as H1 to H2, or emergence of a new hemagglutinin or new neuraminidase, are called antigenic shifts; minor antigenic variations within the same subtypes are called antigenic drifts. Antigenic shift has occurred only with influenza A, usually at irregular intervals of . . . [Go to Full Text]


Related Articles

Summary of Major Changes in the 2003 Red Book
Red Book 2003 2003: 1. [Extract] [Full Text]

Vaccine Safety and Contraindications
Red Book 2003 2003: 37-49. [Extract] [Full Text]

Preterm and Low Birth Weight Infants
Red Book 2003 2003: 66-68. [Extract] [Full Text]

International Travel
Red Book 2003 2003: 93-98. [Extract] [Full Text]

Pregnancy
Red Book 2003 2003: 68-69. [Extract] [Full Text]

Immunocompromised Children
Red Book 2003 2003: 69-81. [Extract] [Full Text]

Children With Chronic Diseases
Red Book 2003 2003: 82. [Extract] [Full Text]

Children in Residential Institutions
Red Book 2003 2003: 85-87. [Extract] [Full Text]

School Health
Red Book 2003 2003: 137-146. [Extract] [Full Text]

Human Immunodeficiency Virus Infection
Red Book 2003 2003: 360-382. [Extract] [Full Text]

Kawasaki Syndrome
Red Book 2003 2003: 392-395. [Extract] [Full Text]

Antiviral Drugs for Non-Human Immunodeficiency Virus Infections
Red Book 2003 2003: 729-732. [Extract] [Full Text]